Quarterly Statement Of Cash Flows

Kringle Pharma,Inc. - Filing #7338974

Concept 2023-10-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
As at
2023-03-31
2022-10-01 to
2023-03-31
As at
2022-09-30
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-365,471,000 JPY
-314,811,000 JPY
Decrease (increase) in trade receivables
7,560,000 JPY
JPY
Decrease (increase) in inventories
51,000 JPY
-7,437,000 JPY
Other, net
22,000 JPY
2,672,000 JPY
Subtotal
-349,781,000 JPY
-295,870,000 JPY
Income taxes paid
-1,491,000 JPY
-1,490,000 JPY
Net cash provided by (used in) operating activities
-315,253,000 JPY
-294,458,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-121,363,000 JPY
-120,875,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
668,409,000 JPY
2,600,000 JPY
Net increase (decrease) in cash and cash equivalents
231,792,000 JPY
-412,734,000 JPY
Cash and cash equivalents
1,993,032,000 JPY
1,761,239,000 JPY
2,089,311,000 JPY
2,502,046,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.